83 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Brainstorm Cell Therapeutics Funding History

Since Brainstorm Cell Therapeutics was founded in 2000, it has participated in 18 rounds of funding. In total Brainstorm Cell Therapeutics has raised $51.7M. Brainstorm Cell Therapeutics' last funding round was on May 2026 for a total of $400.0K.

Brainstorm Cell Therapeutics Funding Rounds

Unlock 15 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Private Placement
May 2026
$400K
__
Private Placement
Feb 2026
$1M
__
Private Placement
Feb 2026
$1M
__
Post-IPO Equity
Jun 2024
$4M
__
Post-IPO Equity
Jul 2023
$7.5M
__

Total Funding: $51.7M

Brainstorm Cell Therapeutics Investors

Unlock 1 more investor →

INVESTOR

ROUND

FUNDING DATE

The ALS Association
Grant
Jun 2020
I AM ALS
Grant
Jun 2020
U.S. Small Business Administration.
Debt - PPP (CARES Act)
Apr 2020
National Multiple Sclerosis Society
Grant
Nov 2019

Total Investors: 4

Brainstorm Cell Therapeutics has 4 investors, including The ALS Association, I AM ALS and U.S. Small Business Administration.. The latest investment occurred in May 2026.